The 18th International Conference on Brain Edema and Cellular Injury was recently held as part of the 11th International Symposium on Neuroprotection and Neurorepair in Potsdam, Germany, from November 18 to 20, 2024. The conference focused on advanced research into brain edema, cellular injury, and mechanisms related to neuroprotection.

The program included sessions on topics such as neuroinflammation, drug delivery to the brain, neuronal plasticity, and advances in therapies for ischemic stroke and brain injuries.

We had the opportunity to present the communication: “New Advances in Experimental Thrombolytic Formulations for the Treatment of Ischaemic Stroke.”

The study is published in collaboration with the Bionanotools group at CIQUS and demonstrates the utility of encapsulating stroke treatments in particles generated with human platelet membranes.

Our researcher Clara Correa presented a study on thrombolytic therapy for ischemic stroke using biomimetic nanoparticles at the BiointegraSaúde conference held at CHUAC in A Coruña on December 14. She won the award for best communication.

The project is supported and co-financed by the Ignicia Program of the Galician Innovation Agency of the Xunta de Galicia.

Members of the TREAT group traveled to Basel to attend the 10th European Stroke Organisation Conference – ESOC 2024, held from May 15-17.

Ana Bugallo, one of our predoctoral students, had the pleasure of presenting her poster titled: “Generation of Human iPSCs with Exonic Variants from CADASIL Patients and Proteomic Comparative Analysis.” Additionally, Dr. María Pérez presented one of our studies digitally, titled: “Preclinical Multicenter Comparison Between Tenecteplase and Alteplase for Acute Stroke.”

Esteban López Arias, member of TREAT team, presented a study on the importance of sham groups in experimental studies at the XVII SECAL Congress, which was held in Santiago de Compostela from November 14 to 17, 2023

http://(https://secal2023.es/index.php).